The FDA is concerned that Trevena's oliceridine, an opioid injection treatment for acute pain, bears too great a risk for abuse. An FDA panel is scheduled to vote Thursday on the drug's safety.
FDA panel to vote on safety of Trevena's opioid treatment
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.